Benefit of Treatment With Sebelipase-Alfa in a 63-Year-Old Patient With Advanced Liver and Atherosclerotic Disease Due to Lysosomal Acid Lipase Deficiency (LAL-D).

Authors :: Aigner E
Feldman A
Neureiter D
Datz C
Ratziu V
Paulweber B
Source :: The American journal of gastroenterology [Am J Gastroenterol] 2018 Mar; Vol. 113 (3), pp. 443-445.
Publication Year :: 2018

Subjects :: Atherosclerosis etiology
Carotid Stenosis etiology
Cholesterol Ester Storage Disease complications
Cholesterol Ester Storage Disease drug therapy
Esophageal and Gastric Varices etiology
Female
Hepatomegaly etiology
Humans
Hypertension, Portal etiology
Liver Diseases etiology
Middle Aged
Treatment Outcome
Umbilical Veins
Wolman Disease complications
Wolman Disease
Enzyme Replacement Therapy
Sterol Esterase therapeutic use
Wolman Disease drug therapy

Full Text Access

Tools